<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05047653</url>
  </required_header>
  <id_info>
    <org_study_id>RALE-CORADS</org_study_id>
    <nct_id>NCT05047653</nct_id>
  </id_info>
  <brief_title>RALE Versus CORADS/CT-Severity Score in COVID-19</brief_title>
  <acronym>RALE-CORADS</acronym>
  <official_title>The Prognostic Value of the Abnormalities on the Chest Radiography Versus the Chest Computed Tomography in Critically Ill COVID-19 Patients - Protocol for a National Study Comparing the RALE With the CORADS and CT-Severity Score</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale Patients with severe coronavirus disease 2019 (COVID-19) frequently fulfill the&#xD;
      criteria for acute respiratory distress syndrome (ARDS), with extensive and bilateral&#xD;
      abnormalities on the chest radiography (CXR) and the chest computed tomography (CT)&#xD;
      abnormalities. The 'Radiographic Assessment of Lung Edema' (RALE) score, the 'COVID-19&#xD;
      Reporting and Data System' (CO-RADS) score, and the 'CT severity score' may all have&#xD;
      prognostic value in critically ill patients with acute respiratory failure due to COVID-19.&#xD;
&#xD;
      Objectives To compare the prognostic value of the RALE score, the CO-RADS score and the CT&#xD;
      severity score in critically ill patients with ARDS due to COVID-19.&#xD;
&#xD;
      Hypotheses The RALE score, the CO-RADS score and the CT severity score have prognostic value&#xD;
      (primary). The RALE score, the CO-RADS score and the CT severity score correlate well.&#xD;
&#xD;
      Study design National, retrospective observational study. Study population Critically ill&#xD;
      COVID-19 patients with acute respiratory failure, who received at least one CXR and one chest&#xD;
      CT scan during critical illness.&#xD;
&#xD;
      Method CXRs are visually scored by two independent investigators, using the RALE score&#xD;
      approach. Chest CT scans are scored by an independent radiologist, using the CO-RADS score&#xD;
      and the CT severity score. Demographic, ventilation and outcome data are captured from the&#xD;
      hospital systems.&#xD;
&#xD;
      Main study parameters/endpoints ICU mortality (primary) and hospital-, 28-, 90-mortality, the&#xD;
      number of days alive and free from invasive ventilation, duration of ventilation in&#xD;
      survivors, and length of stay in ICU and hospital.&#xD;
&#xD;
      Nature and extent of the burden and risks associated with participation, benefit and group&#xD;
      relatedness Participants will not directly benefit from participation, but burden is absent.&#xD;
      The CRX and chest CT scans have already been obtained as part of routine clinical care.&#xD;
      Collecting CXR for RALE scoring and chest CT scans for CO-RADS and CT severity scoring,&#xD;
      clinical and outcome data is of no harm for individual patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 14, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>90 days</time_frame>
    <description>The ICU mortality with a maximum of 90 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hospital mortality</measure>
    <time_frame>90 days</time_frame>
    <description>The hospital mortality with a maximum of 90 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28 days</time_frame>
    <description>The 28-day mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90-day mortality</measure>
    <time_frame>90 days</time_frame>
    <description>The 90-day mortality</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COVID-19 Pneumonia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>RALE score vs. severity score</intervention_name>
    <description>RALE score vs. severity score and CORADS</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Invasive ventilated COVID-19 patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  admitted to the intensive care unit of the Amsterdam UMC, location 'AMC', between&#xD;
             March 1, 2020 and May 31, 2020 (the first 3 months of the first wave of the national&#xD;
             outbreak in the Netherlands) and between October 1, 2020 and December 31, 2020 (the&#xD;
             first 3 months of the second wave in the Netherlands);&#xD;
&#xD;
          -  RT-PCR confirmed coronavirus diseases 2019 (COVID-19); and&#xD;
&#xD;
          -  having had received at least one chest radiograph (CXR) and one adjacent chest&#xD;
             computed tomography (CT) scan during the period a patient was having acute respiratory&#xD;
             failure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Christel Valk, MD</last_name>
    <phone>0205669111</phone>
    <email>c.m.valk@amsterdamumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcus Schultz, MD, PhD</last_name>
    <phone>0205669111</phone>
    <email>marcus.j.schultz@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus J Schultz, MD PhD</last_name>
      <email>marcus.j.schultz@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Lieuwe D Bos, MD PhD</last_name>
      <email>l.d.bos@amsterdamumc.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 14, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Marcus J. Schultz</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>RALE score</keyword>
  <keyword>severity score</keyword>
  <keyword>CORADS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

